PatternsRadar
Sign in

SAIPARENTSai Parenterals Limited

NSE
492.30INR-3.10 (-0.63%)Close · 20 Nov 2026
1 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹2,175 CrMarket cap
87.2P/E (TTM)
43.5%Delivery

Filings & corporate actions

3 results filed
CSV
Next results · Q3 FY27
Expected 1 Feb 2027 – 22 Feb 2027
Estimate: filed 32–53 days after quarter end, last 3 times
2026
  • 1 NovresultsResults · Q2 FY27 · consolidated and standalone-7.9%NSE
  • 16 OctshareholdingShareholding · 30 Sept 2026+0.7%NSE
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone-3.7%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-1.5%NSE
  • 23 MayresultsResults · Q3 FY26 · consolidated and standalone+0.6%NSE
  • 23 MayresultsResults · Q4 FY26 · consolidated and standalone+0.6%NSE
  • 15 AprshareholdingShareholding · 31 Mar 2026+2.4%NSE
  • 2 AprshareholdingShareholding · 1 Apr 2026NSE

Reaction to results · all yearsrose on day 0 in 2 of 4 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY271 Nov 2026-7.9%-7.4%—3.0×
Q1 FY2711 Aug 2026-3.7%-5.8%-8.3%3.0×
Q4 FY2623 May 2026+0.6%+3.0%+23.3%2.7×
Q3 FY2623 May 2026+0.6%+3.0%+23.3%2.7×
Average-2.6%-1.8%+12.8%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ+9.1%
Profit QoQ+32.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open495.40
Day range480.00 – 495.40
52-week range—
From 52w high—
RSI (14)49.3
ATR (14)22.55
Volume1.21L
Avg volume (20D)1.61L
Rel volume0.75×
Volatility (1Y)37.1%
Turnover₹5.9Cr
Traded value (NSE)₹5.9Cr
VWAP486.17
SMA 50 / 200497.98 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202643.5%
20-day avg48.6%
1-year avg54.5%
Percentile (own history)15th
Range21.0–92.7%
Sessions159

Over the last 20 sessions SAIPARENT settled 48.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 54.5%, so recent sessions are running 5.9 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders13.6K · +46.5% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy141 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.63%-0.92%+9.04%-9.40%+2.54%—

Valuation

Market cap₹2,175 Cr
Market cap (NSE)₹2,175 Cr
Free-float cap₹1,062 Cr
P/E (TTM)87.2
EPS (TTM)5.64
P/B4.4
Net margin (TTM)3.7%
Other income / PBT65.9%
ROE5.0%
Debt / equity0.70
Shares outstanding—
Listed2 Apr 2026

Ownership

Promoter51.16%
Promoter Δ QoQ0.00 pp
Public48.84%
FII2.85%
DII7.84%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)96.2197.9178.7194.9
YoY chg————
Net profit (₹ Cr)(6.7)13.27.910.5
YoY chg————
Net margin-6.9%6.6%4.4%5.4%
EPS-2.224.021.792.38

Shareholding over time

By quarter

30 Sept 2026 · promoter 51.16% · public 48.84%
31 Mar 2026: promoter 51.16%1 Apr 2026: promoter 51.16%30 Jun 2026: promoter 51.16%30 Sept 2026: promoter 51.16%
2026-032026-09
  • Promoter
  • Public and others
Promoter
51.16%
Public
48.84%
Promoter change
0.00 pp
Filed
16 Oct 2026
FII
2.85%
DII
7.84%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.30%

-0.68 pp QoQ

Insurance
2.35%

0.00 pp QoQ

FPI
2.85%

-1.18 pp QoQ

Retail ≤ ₹2L
9.56%

+2.77 pp QoQ

HNI > ₹2L
18.88%

+0.33 pp QoQ

NRI
0.61%

+0.05 pp QoQ

Bodies corporate
5.34%

-1.92 pp QoQ

Shareholders
13,645

+46.5% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Vijitha GorrepatiPromoter · Individual28.91%
Anil Kumar KarusalaPromoter · Individual10.32%
ARUNA KARUSALAPromoter · Individual7.40%
BHASKARA RAO BOLLINENIIndividual4.56%
Kunal KakumanuPromoter · Individual4.53%
SAMARSH CAPITAL-SAMARSH CAPITAL-FUND IAIF3.45%
KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD.Insurance2.35%
AIG DIRECT LLCCorporate2.12%
AGILIS PARTNERS LLPCorporate2.06%
KOTAK LIFE SCIENCES FUND IAIF1.73%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Bulk & block deals · 2 Jul 2026

CSV
4 of 4 deals
By year
DateDealClientQuantityPriceValue
2 Jul 2026Sell · bulkHRTI PRIVATE LIMITED2.27L637.95₹14.5Cr
2 Jul 2026Buy · bulkHRTI PRIVATE LIMITED1.05L639.68₹6.7Cr
9 Apr 2026Buy · bulkARIHANT CAPITAL MARKETS LIMITED3.98L423.13₹16.8Cr
7 Apr 2026Buy · bulkBHASKARA RAO BOLLINENI5.12L409.25₹21.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 25 May 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations96.2197.9178.7194.9
Other income3.12.93.73.7
Total income99.3200.8182.4198.6
Total expenses110.9188.4172.6188.7
└ Finance costs5.48.49.49.0
└ Depreciation5.88.28.125.1
Profit before tax(11.6)12.49.89.9
Tax expense(5.0)(0.8)1.9(0.6)
Net profit(6.7)13.27.910.5
EPS-2.224.021.792.38
Net margin-6.93%6.65%4.43%5.39%
PBT margin-12.09%6.26%5.48%5.07%
Tax rate—-6.16%19.07%-6.28%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 1 Nov 2026.

4 quarters on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

₹ crore, as filed

Balance sheet

 FY26H1 FY27
Total assets1,424.21,319.8
Current assets822.0635.0
└ Cash & equivalents417.0129.3
└ Other bank balances0.00.0
└ Current investments0.00.0
└ Trade receivables181.0254.5
└ Inventories171.8182.2
Total equity495.1508.1
└ Attributable to owners490.8495.8
└ Non-controlling interest4.412.3
└ Share capital22.122.1
Borrowings319.5356.6
└ Current229.1275.4
└ Non-current90.481.2
Trade payables148.6127.4
Current liabilities572.6464.1
Total liabilities929.1811.7
Net debt(97.5)227.3
Debt / equity0.650.70
Current ratio1.441.37

Cash flow, year to date

 FY26H1 FY27
Operating cash flow93.1(205.5)
└ Capex(65.5)(51.5)
Free cash flow27.6(256.9)
Investing cash flow(273.8)(69.8)
Financing cash flow595.7(12.3)
└ Dividends paid0.00.0
└ Buybacks0.00.0
Net change in cash414.9(287.6)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SAIPARENT at a glance

  • SAIPARENT closed at ₹492.3 on 20 Nov 2026, -0.63% on the day.
  • Delivery was 43.5% of traded quantity on 20 Nov 2026, the 15th percentile of its own 159 sessions with a reading (20-session average 48.6%, 1-year average 54.5%).
  • Market capitalisation is ₹2,175 crore at a trailing P/E of 87.2 (trailing EPS ₹5.64).
  • Q2 FY27 results (consolidated, filed 1 Nov 2026): revenue ₹195 crore, net profit ₹11 crore; the price moved -7.9% on the first session after.
  • Promoters held 51.16% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 1 Feb 2027 and 22 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0H9F01037
SeriesEQ
Listed2 Apr 2026
IPO price392.00 · band Rs.372 to Rs.392
IPO listing2 Apr 2026
NSE market cap · 17 Nov 2026₹2,194 Cr
Free-float market cap (NSE)₹593 Cr
Shares outstanding (NSE)4.42Cr
History from2 Apr 2026
Sessions159

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.